HBV-话题@MedSci

#HBV#

159篇内容 | 6831人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1836647, encodeId=4035183664eca, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Mediterr J Hematol Infect Dis：Burkina Faso（非洲一国家）的隐匿性HBV感染的流行率和相关基因型, objectType=article, longId=126617, objectId=2c7412661ee8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c7412661ee8, replyNumber=0, likeNumber=37, createdTime=2018-05-26, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c7412661ee8, moduleTitle=Mediterr J Hematol Infect Dis：Burkina Faso（非洲一国家）的隐匿性HBV感染的流行率和相关基因型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c7412661ee8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836620, encodeId=379d183662002, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Sci Rep：血清HBcrAg是乙肝HBV-DNA的一种新型标志物！, objectType=article, longId=91644, objectId=afcb9164437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afcb9164437, replyNumber=0, likeNumber=83, createdTime=2017-05-23, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afcb9164437, moduleTitle=Sci Rep：血清HBcrAg是乙肝HBV-DNA的一种新型标志物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afcb9164437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836630, encodeId=1bd1183663061, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Oncotarget：BEX2或是HBV感染肝细胞癌患者一个新型治疗靶点！, objectType=article, longId=109024, objectId=445110902408, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=445110902408, replyNumber=0, likeNumber=68, createdTime=2018-05-03, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=445110902408, moduleTitle=Oncotarget：BEX2或是HBV感染肝细胞癌患者一个新型治疗靶点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=445110902408)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836629, encodeId=3c4e183662914, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=PLoS One：来自南非的经验：对妊娠妇女产前HBV感染的快速筛查, objectType=article, longId=106461, objectId=9054106461fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9054106461fd, replyNumber=0, likeNumber=64, createdTime=2018-04-30, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9054106461fd, moduleTitle=PLoS One：来自南非的经验：对妊娠妇女产前HBV感染的快速筛查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9054106461fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836632, encodeId=22b81836632f8, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Hepatology：恩替卡韦单药初治HBV患者存在LLV是否有长期不良影响？, objectType=article, longId=112176, objectId=78e31121e657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78e31121e657, replyNumber=0, likeNumber=67, createdTime=2018-07-27, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78e31121e657, moduleTitle=Hepatology：恩替卡韦单药初治HBV患者存在LLV是否有长期不良影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78e31121e657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836626, encodeId=fc78183662694, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Plos One：肺癌化疗期间HBV病毒的复燃和预防性抗病毒治疗：一项系统回顾和meta分析, objectType=article, longId=103334, objectId=408a103334eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=408a103334eb, replyNumber=0, likeNumber=82, createdTime=2018-02-18, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=408a103334eb, moduleTitle=Plos One：肺癌化疗期间HBV病毒的复燃和预防性抗病毒治疗：一项系统回顾和meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=408a103334eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836639, encodeId=ce9618366390f, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=《2017年意大利共识指南：血液系统恶性肿瘤以及接受造血干细胞移植患者HBV再激活的筛查、监测、预防和预防性治疗的建议》摘译, objectType=article, longId=120876, objectId=6b8d1208e6ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b8d1208e6ba, replyNumber=0, likeNumber=31, createdTime=2018-06-14, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b8d1208e6ba, moduleTitle=《2017年意大利共识指南：血液系统恶性肿瘤以及接受造血干细胞移植患者HBV再激活的筛查、监测、预防和预防性治疗的建议》摘译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b8d1208e6ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836622, encodeId=149d183662243, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Hepatology：隐性HBV携带者干细胞移植后再激活的前瞻性研究, objectType=article, longId=93481, objectId=9d5793481d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d5793481d8, replyNumber=0, likeNumber=72, createdTime=2017-05-01, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d5793481d8, moduleTitle=Hepatology：隐性HBV携带者干细胞移植后再激活的前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d5793481d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836624, encodeId=e12e183662489, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Cancer：你会选择进行HBV筛选么？, objectType=article, longId=98569, objectId=e64898569b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e64898569b9, replyNumber=0, likeNumber=87, createdTime=2017-12-03, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e64898569b9, moduleTitle=Cancer：你会选择进行HBV筛选么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e64898569b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836635, encodeId=7c6c183663589, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=病例分享：「HBsAg转阳」一例HBV复活案例, objectType=article, longId=115108, objectId=33e91151088a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33e91151088a, replyNumber=0, likeNumber=132, createdTime=2018-09-06, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33e91151088a, moduleTitle=病例分享：「HBsAg转阳」一例HBV复活案例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33e91151088a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836619, encodeId=4be71836619e5, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=医护人员职业暴露后处理流程详解（HBV、HCV、TP、HIV）, objectType=article, longId=88530, objectId=ac508853045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac508853045, replyNumber=0, likeNumber=81, createdTime=2017-11-12, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac508853045, moduleTitle=医护人员职业暴露后处理流程详解（HBV、HCV、TP、HIV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac508853045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836631, encodeId=dc1418366315a, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Hepatology：HBV pgRNA用于乙型肝炎相关肝癌的肿瘤分型和预后预测, objectType=article, longId=110604, objectId=5a4b11060405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a4b11060405, replyNumber=0, likeNumber=88, createdTime=2018-06-25, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a4b11060405, moduleTitle=Hepatology：HBV pgRNA用于乙型肝炎相关肝癌的肿瘤分型和预后预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a4b11060405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836628, encodeId=4b7018366286e, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Cell Physiol Biochem：全基因组关联研究MKI67表达对中国南方地区HBV相关的肝癌的临床意义, objectType=article, longId=105738, objectId=a662105e3843, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a662105e3843, replyNumber=0, likeNumber=89, createdTime=2018-03-24, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a662105e3843, moduleTitle=Cell Physiol Biochem：全基因组关联研究MKI67表达对中国南方地区HBV相关的肝癌的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a662105e3843)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836627, encodeId=0ef1183662e27, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Antiviral Res：在哺乳动物和植物细胞中产生的一个新的嵌合的HBV S/preS1抗原会引起比标准的疫苗成分S蛋白质更强的体液和细胞免疫反应, objectType=article, longId=104502, objectId=60b4104502a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60b4104502a5, replyNumber=0, likeNumber=68, createdTime=2017-10-19, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60b4104502a5, moduleTitle=Antiviral Res：在哺乳动物和植物细胞中产生的一个新的嵌合的HBV S/preS1抗原会引起比标准的疫苗成分S蛋白质更强的体液和细胞免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60b4104502a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836621, encodeId=3eba18366213c, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Hepatology：他汀再添新作用：降低HBV、HCV肝硬化患者失代偿风险, objectType=article, longId=92871, objectId=dd2c928e1a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd2c928e1a9, replyNumber=0, likeNumber=80, createdTime=2017-12-22, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd2c928e1a9, moduleTitle=Hepatology：他汀再添新作用：降低HBV、HCV肝硬化患者失代偿风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd2c928e1a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836617, encodeId=5b83183661e69, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【收藏】医护人员职业暴露后处理流程详解（HBV、HCV、TP、HIV）, objectType=article, longId=78597, objectId=e0ece8597d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0ece8597d8, replyNumber=0, likeNumber=149, createdTime=2016-10-12, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0ece8597d8, moduleTitle=【收藏】医护人员职业暴露后处理流程详解（HBV、HCV、TP、HIV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0ece8597d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836616, encodeId=2d1b1836616e8, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=J Hepatol：全球HBV感染情况分析, objectType=article, longId=77171, objectId=cddfe717119, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cddfe717119, replyNumber=0, likeNumber=77, createdTime=2017-01-10, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cddfe717119, moduleTitle=J Hepatol：全球HBV感染情况分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cddfe717119)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836623, encodeId=fecd18366236d, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=Gut：原代肝细胞增殖和预防HBV再感染有效地消耗体内细胞核内cccDNA！, objectType=article, longId=96722, objectId=8df596e229c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8df596e229c, replyNumber=0, likeNumber=75, createdTime=2017-05-02, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8df596e229c, moduleTitle=Gut：原代肝细胞增殖和预防HBV再感染有效地消耗体内细胞核内cccDNA！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8df596e229c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836612, encodeId=e4eb18366129c, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=APT：仅有1.2%的患者能够完全清除HBV病毒, objectType=article, longId=72471, objectId=8c01e2471ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c01e2471ba, replyNumber=0, likeNumber=53, createdTime=2017-06-09, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c01e2471ba, moduleTitle=APT：仅有1.2%的患者能够完全清除HBV病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c01e2471ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1836614, encodeId=892c18366141f, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=利用CRISPR/Cas9系统治疗HBV感染取得突破性进展, objectType=article, longId=73883, objectId=802ce3883fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=802ce3883fa, replyNumber=0, likeNumber=63, createdTime=2017-04-05, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=802ce3883fa, moduleTitle=利用CRISPR/Cas9系统治疗HBV感染取得突破性进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=802ce3883fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HBV

2020-05-29

klivis (审核中...)

前往app查看评论内容

#HBV#

Mediterr J Hematol Infect Dis：Burkina Faso（非洲一国家）的隐匿性HBV感染的流行率和相关基因型

2018-05-26

klivis (审核中...)

前往app查看评论内容

#HBV#

Sci Rep：血清HBcrAg是乙肝HBV-DNA的一种新型标志物！

2017-05-23

klivis (审核中...)

前往app查看评论内容

#HBV#

Oncotarget：BEX2或是HBV感染肝细胞癌患者一个新型治疗靶点！

2018-05-03

klivis (审核中...)

前往app查看评论内容

#HBV#

PLoS One：来自南非的经验：对妊娠妇女产前HBV感染的快速筛查

2018-04-30

klivis (审核中...)

前往app查看评论内容

#HBV#

Hepatology：恩替卡韦单药初治HBV患者存在LLV是否有长期不良影响？

2018-07-27

klivis (审核中...)

前往app查看评论内容

#HBV#

Plos One：肺癌化疗期间HBV病毒的复燃和预防性抗病毒治疗：一项系统回顾和meta分析

2018-02-18

klivis (审核中...)

前往app查看评论内容

#HBV#

《2017年意大利共识指南：血液系统恶性肿瘤以及接受造血干细胞移植患者HBV再激活的筛查、监测、预防和预防性治疗的建议》摘译

2018-06-14

爆笑小医 (审核中...)

前往app查看评论内容

#HBV#

Hepatology：隐性HBV携带者干细胞移植后再激活的前瞻性研究

2017-05-01

klivis (审核中...)

前往app查看评论内容

#HBV#

Cancer：你会选择进行HBV筛选么？

2017-12-03

klivis (审核中...)

前往app查看评论内容

#HBV#

病例分享：「HBsAg转阳」一例HBV复活案例

2018-09-06

docwu2019 (审核中...)

前往app查看评论内容

#HBV#

医护人员职业暴露后处理流程详解（HBV、HCV、TP、HIV）

2017-11-12

klivis (审核中...)

前往app查看评论内容

#HBV#

Hepatology：HBV pgRNA用于乙型肝炎相关肝癌的肿瘤分型和预后预测

2018-06-25

klivis (审核中...)

前往app查看评论内容

#HBV#

Cell Physiol Biochem：全基因组关联研究MKI67表达对中国南方地区HBV相关的肝癌的临床意义

2018-03-24

klivis (审核中...)

前往app查看评论内容

#HBV#

Antiviral Res：在哺乳动物和植物细胞中产生的一个新的嵌合的HBV S/preS1抗原会引起比标准的疫苗成分S蛋白质更强的体液和细胞免疫反应

2017-10-19

klivis (审核中...)

前往app查看评论内容

#HBV#

Hepatology：他汀再添新作用：降低HBV、HCV肝硬化患者失代偿风险

2017-12-22

klivis (审核中...)

前往app查看评论内容

#HBV#

【收藏】医护人员职业暴露后处理流程详解（HBV、HCV、TP、HIV）

2016-10-12

klivis (审核中...)

前往app查看评论内容

#HBV#

J Hepatol：全球HBV感染情况分析

2017-01-10

klivis (审核中...)

前往app查看评论内容

#HBV#

Gut：原代肝细胞增殖和预防HBV再感染有效地消耗体内细胞核内cccDNA！

2017-05-02

klivis (审核中...)

前往app查看评论内容

#HBV#

APT：仅有1.2%的患者能够完全清除HBV病毒

2017-06-09

klivis (审核中...)

前往app查看评论内容

#HBV#

利用CRISPR/Cas9系统治疗HBV感染取得突破性进展

2017-04-05

科室
- - 订阅+
  - 更多科室
工具
服务